Northern Trust
ENZN

Northern Trust’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Northern Trust’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-82,058
Closed -$38K – 4320
2016
Q1 		$38K Hold
82,058
– – ﹤0.01% 4060
2015
Q4 		$56K Hold
82,058
– – ﹤0.01% 4036
2015
Q3 		$80K Sell
82,058
-14,915
-15% -$18.4K ﹤0.01% 3989
2015
Q2 		$117K Sell
96,973
-12,492
-11% -$15.9K ﹤0.01% 3923
2015
Q1 		$116K Sell
109,465
-3,949
-3% -$4.08K ﹤0.01% 4004
2014
Q4 		$123K Buy
113,414
+588
+0.5% +$617 ﹤0.01% 3940
2014
Q3 		$122K Sell
112,826
-293,529
-72% -$362K ﹤0.01% 3982
2014
Q2 		$423K Sell
406,355
-86,236
-18% -$82.2K ﹤0.01% 3646
2014
Q1 		$507K Sell
492,591
-48,365
-9% -$49.9K ﹤0.01% 3545
2013
Q4 		$628K Buy
540,956
+274
+0.1% +$422 ﹤0.01% 3474
2013
Q3 		$909K Sell
540,682
-25,760
-5% -$47.7K ﹤0.01% 3357
2013
Q2 		$1.13M Buy
+566,442
New +$1.66M ﹤0.01% 3233

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Northern Trust's ENZN Position: Q2 2016 in Review

Northern Trust sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 82,058 shares — an estimated $38K sold.

Northern Trust first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $1.13M in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Northern Trust reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Northern Trust sold 82,058 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $38K.
  • Northern Trust first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Northern Trust's ENZON PHARMACEUTICALS INC position peaked at $1.13M in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Northern Trust's 13F filing for Q2 2016, filed 12 Aug 2016.